Journal article · 2024
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
New England Journal of Medicine, 391(9), 867–869 · Published 4 September 2024 · DOI 10.1056/nejmc2408786
In brief
“BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease” is a 2024 journal article by Melanie Hagen and 16 co-authors, published in New England Journal of Medicine. OpenAlex counts 168 citations as of 20 November 2026, which puts it in the top 2% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 168
- Most cited in
- 2026 (85)
- Field-weighted impact
- 23.48
- References
- 4
- Authors
- 17
Abstract
In four patients with severe autoimmune disease, teclistimab, a bispecific antibody to B-cell maturation antigen and CD3, resulted in autoantibody reduction and clinical response after short-term follow-up. Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hagen, M., Bucci, L., Boeltz, S., Nöthling, D.-M., Rothe, T., Anoshkin, K., Raimondo, M. G., Tur, C., Wirsching, A., Wacker, J., Düsing, C., Distler, J. H. W., Kuwert, T., Bözec, A., Ramming, A., Schett, G. A., & Grieshaber‐Bouyer, R. (2024). BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease. New England Journal of Medicine, 391(9), 867–869. https://doi.org/10.1056/nejmc2408786
MLA 9
Hagen, Melanie, et al. “BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease.” New England Journal of Medicine, vol. 391, no. 9, 2024, pp. 867–869. https://doi.org/10.1056/nejmc2408786.
Chicago
Hagen, Melanie, Laura Bucci, Sebastian Boeltz, Danae-Mona Nöthling, Tobias Rothe, Kirill Anoshkin, Maria Gabriella Raimondo, et al. 2024. “BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease.” New England Journal of Medicine 391 (9): 867–869. https://doi.org/10.1056/nejmc2408786.
Harvard
Hagen, M. et al. (2024) ‘BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease’, New England Journal of Medicine, 391(9), pp. 867–869. doi:10.1056/nejmc2408786.
IEEE
M. Hagen et al., “BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease,” New England Journal of Medicine, vol. 391, no. 9, pp. 867–869, 2024, doi: 10.1056/nejmc2408786.
BibTeX
@article{hagen2024bcma,
title = {{BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease}},
author = {Hagen, Melanie and Bucci, Laura and Boeltz, Sebastian and Nöthling, Danae-Mona and Rothe, Tobias and Anoshkin, Kirill and Raimondo, Maria Gabriella and Tur, Carlo and Wirsching, Andreas and Wacker, Jochen and Düsing, Christina and Distler, Jörg H. W. and Kuwert, Torsten and Bözec, Aline and Ramming, Andreas and Schett, Georg Andreas and Grieshaber‐Bouyer, Ricardo},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {9},
pages = {867--869},
doi = {10.1056/nejmc2408786},
url = {https://doi.org/10.1056/nejmc2408786}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 6 | |
| 2025 | 77 | |
| 2026 | 85 |
Its field-weighted citation impact is 23.48: it has been cited 23.48 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- BCMA
- T-cell engagers
- bispecific antibodies
- autoimmune disease
- autoantibodies
- CD3
- clinical response
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Hagen, M., Bucci, L., Boeltz, S., Nöthling, D.-M., Rothe, T., Anoshkin, K., Raimondo, M. G., Tur, C., Wirsching, A., Wacker, J., Düsing, C., Distler, J. H. W., Kuwert, T., Bözec, A., Ramming, A., Schett, G. A., & Grieshaber‐Bouyer, R. (2024). BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease. New England Journal of Medicine, 391(9), 867–869. https://doi.org/10.1056/nejmc2408786
How many times has this paper been cited?
168 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Melanie Hagen, Laura Bucci, Sebastian Boeltz, Danae-Mona Nöthling, Tobias Rothe, Kirill Anoshkin, Maria Gabriella Raimondo, Carlo Tur, Andreas Wirsching, Jochen Wacker, Christina Düsing, Jörg H. W. Distler and 5 more.
What is the DOI of this paper?
10.1056/nejmc2408786, permanently at https://doi.org/10.1056/nejmc2408786. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.